Breaks Categories: News

WednesdayJul 09, 2025 10:43 am

NetworkNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Sees Growth Ahead with AI Drone Tech Following $33 Billion Federal Defense Bill 

Safe Pro Group (NASDAQ: SPAI) announced that the recently enacted One Big Beautiful Bill Act (OBBBA), which allocates $33 billion in U.S. government spending for drones and AI, presents major growth opportunities for its AI-powered drone imagery analysis technology. The Company’s SPOTD platform, which can detect over 150 types of explosive threats in real time, is already deployed in conflict zones like Ukraine and is being integrated into the U.S. Army’s ATAK system. With $13.5 billion earmarked for unmanned systems and $16 billion for AI initiatives across defense and border operations, Safe Pro aims to expand its work with the…

Continue Reading

WednesdayJul 09, 2025 9:20 am

NetworkNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Commissions Valuation to Advance Beacon Gold Mill Restart

LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) has engaged Bumigeme Inc. to conduct an independent valuation report of its fully owned Beacon Gold Mill in Val-d'Or, Québec. The report will assess replacement value and restart costs for the mill and tailings facility, which received over $20 million in upgrades in 2022. The valuation aims to support financing efforts and highlight the company’s potential to monetize production at the Beacon Mill, tied to the Swanson Gold Project. LaFleur Minerals is preparing for gold production and a Preliminary Economic Assessment while leveraging favorable market conditions, including J.P. Morgan’s forecast of $4,100…

Continue Reading

WednesdayJul 09, 2025 9:00 am

NetworkNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Targets Multiple 2025–2026 Catalysts Across Rare Disease Pipeline

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company developing therapies for rare diseases with unmet medical needs, issued a shareholder update outlining key clinical and strategic milestones. President and CEO Dr. Christopher J. Schaber highlighted upcoming data readouts for lead candidates, including Phase 3 FLASH 2 results for HyBryte(TM) (synthetic hypericin) in cutaneous T-cell lymphoma expected in 2H 2026, and multiple updates in 3Q and 4Q 2025 across psoriasis (SGX302) and Behçet’s Disease (SGX945). An investigator-initiated study also showed a 75% success rate at 18 weeks. The company projects HyBryte(TM) peak U.S. annual sales of over $90 million and global opportunities…

Continue Reading

TuesdayJul 08, 2025 2:35 pm

NetworkNewsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Emerges from Lottery.com Rebrand with Global Sports, Entertainment and Gaming Vision 

SEGG Media (NASDAQ: SEGG, LTRYW), formerly Lottery.com Inc., has completed its corporate rebrand and strategic overhaul, signaling a new era as a global sports, entertainment, and ethical gaming conglomerate. Trading under the new SEGG ticker, the company now operates across three verticals: Sports.com (live streaming, sim racing, eSports), Entertainment (event streaming, music, fashion), and Lottery.com (iGaming and charity-aligned gaming). Following a $300 million equity line, SEGG Media is focused on non-dilutive growth, asset-backed acquisitions, and fan-first digital experiences, with major initiatives expected in global motorsports, storytelling content, and branded facilities. To view the full press release, visit https://nnw.fm/H3Xgj About SEGG…

Continue Reading

TuesdayJul 08, 2025 12:17 pm

NetworkNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Featured in Editorial Highlighting Breakthrough Genetic Medicine Platform 

  Calidi Biotherapeutics (NYSE American: CLDI) announced its feature in a NetworkNewsWire editorial discussing the company’s precision genetic medicine platform, which targets both primary and metastatic cancer tumors using engineered viruses. With global cancer diagnoses expected to reach 35 million annually by 2050, Calidi’s approach represents a potential breakthrough in addressing critical unmet needs. The company’s platform aims to deliver potent genetic therapies directly to cancer sites, offering a novel and potentially disruptive solution in the fight against cancer. To view the full press release, visit: https://nnw.fm/qQT9S About Calidi Biotherapeutics Calidi Biotherapeutics is a clinical-stage immuno-oncology company with proprietary technology…

Continue Reading

TuesdayJul 08, 2025 12:04 pm

NetworkNewsBreaks – Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Appoints Former Noront CEO Alan Coutts to Board

Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF), a Canadian exploration company, announced the appointment of Alan Coutts to its board of directors. Coutts, a veteran geologist with over 35 years of global mining experience, previously served as President and CEO of Noront Resources, where he led the C$650 million sale of the Eagle's Nest nickel project to Wyloo Metals—the largest nickel acquisition of the past decade. His past roles include senior positions at Xstrata Nickel, Noranda, and Falconbridge. Fathom leadership emphasized Coutts’ expertise in project development and strategic transactions as instrumental to advancing its Albert Lake and Gochager Lake projects…

Continue Reading

TuesdayJul 08, 2025 11:12 am

NetworkNewsBreaks – SolarBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Advances 7.2 MW New York Solar Project Following Key Regulatory Approval

Disseminated on behalf of SolarBank Corporation  SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) announced that its 7.2 MW Hoadley Hill Road ground-mount solar project in upstate New York has cleared the Coordinated Electric System Interconnection Review (CESIR), a major regulatory milestone. The project, which will power approximately 850 homes through New York’s grid, is backed by the state’s VDER compensation mechanism and may qualify for up to US$0.395/W DC in NYSERDA NY-Sun incentives. Structured as a community solar project, it offers residents and businesses bill credits without on-site installations. With over 100 MW built and a pipeline exceeding 1…

Continue Reading

TuesdayJul 08, 2025 10:10 am

NetworkNewsBreaks – Fifty 1 Labs, Inc. (OTC: FITY) Launches Bold AI-Driven Strategy to Reach $50 Million Valuation and Target NASDAQ Uplisting

Fifty 1 Labs (OTC: FITY), a Nevada-based innovator in AI-driven drug repurposing and functional medicine, unveiled a strategic “Game Plan” aimed at achieving a $50 million valuation and uplisting to the OTCQB by Q1 2026, with long-term plans to join the NASDAQ Capital Market. Backed by a $350,000 insider investment and leadership salary deferrals, FITY is advancing its wholly owned subsidiary, Fifty1 AI Labs LLC, with a $1 million R&D initiative to discover repurposed treatments by May 2026. The company will launch a digital platform by July 31, 2025, pursue biotech acquisitions in the $5–10 million range, and host a…

Continue Reading

TuesdayJul 08, 2025 9:35 am

NetworkNewsBreaks – BluSky AI Inc. (OTC: BSAI) Secures 9.3 MW Power and Land for Flagship Utah Data Center

BluSky AI (OTC: BSAI), a developer of modular AI data center infrastructure, announced the acquisition of its first operational site in Central, Utah, securing 9.3 MW of grid-connected power through an agreement with Digital Asset Management, LLC. In exchange for exclusive power rights, BluSky AI issued 20 million shares of restricted stock. The company also signed a ground lease with Wild Mustang Ventures LLC for 51.6 acres, with an option to purchase. These agreements position BluSky AI to launch and scale its flagship data center project with long-term power stability and operational control. To view the full press release, visit…

Continue Reading

TuesdayJul 08, 2025 9:30 am

NetworkNewsBreaks – Fifty 1 Labs, Inc. (OTC: FITY) Launches Bold AI-Driven Strategy to Reach $50 Million Valuation and Target NASDAQ Uplisting 

Fifty 1 Labs (OTC: FITY), a Nevada-based innovator in AI-driven drug repurposing and functional medicine, unveiled a strategic “Game Plan” aimed at achieving a $50 million valuation and uplisting to the OTCQB by Q1 2026, with long-term plans to join the NASDAQ Capital Market. Backed by a $350,000 insider investment and leadership salary deferrals, FITY is advancing its wholly owned subsidiary, Fifty1 AI Labs LLC, with a $1 million R&D initiative to discover repurposed treatments by May 2026. The company will launch a digital platform by July 31, 2025, pursue biotech acquisitions in the $5–10 million range, and host a…

Continue Reading